IN
INNOCAN PHARMA Corp
INNPF · OTC
$1.60 -8.05% (-$0.14)
1M +18.24%
Market Cap $7.20M
P/E Ratio -
Div. Yield -
ROE 13.58%
Piotroski F-Score Weak
3/9Valuation
99 /100
Cheap EV/EBITDA 1.14x
P/B 1.71x
P/S 0.24x
Growth
-
N/A EPS growth N/A
Book val. growth N/A
Rev. growth N/A
Profitability
22 /100
Weak Gross margin 88.90%
FCF margin 0.54%
Net margin 2.21%
Quality
17 /100
Poor ROIC 1.93%
Asset turnover 2.69x
ROE 13.58%
Debt
99 /100
Low Debt/Equity 0.33x
Net debt/EBITDA -5.00x
Current ratio 3.70x
Stability
50 /100
Moderate Beta -0.22x
Rev. volatility N/A
Profitable years N/A
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o INNPF
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Iris Bincovich
Employees
11
Headquarters
Calgary